Postoperative long term chemotherapy for advanced gastric cancer
- Cite this article as:
- Kaibara, N., Soejima, K., Nakamura, T. et al. The Japanese Journal of Surgery (1976) 6: 54. doi:10.1007/BF02468887
- 18 Downloads
A postoperative long term chemotherapy was carried out against stage IV gastric cancer with Mitomycin-C, Futraful and a plant polysaccharide, PS-K. The 2-year survival rate was 15 per cent in patients who received an intraoperative Mitomycin-C alone, while it increased to 34 per cent in those receiving the anticancer agents for a prolonged period. The postoperative long term chemotherapy is assumed to be an effective means of improving the therapeutical results of gastric cancer.